Drug Approvals
🇺🇸 FDA Page 6FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 61–72 of 665 articles
Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN
FDA · IgAN · 6 min
Dr. Sarah MitchellThe FDA Amendments Act And Drug Safety: Twenty Years Later
FDA · 5 min
Dr. Sarah MitchellFDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities
FDA · 4 min
Dr. Sarah MitchellFriday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials
4 min
Dr. Sarah MitchellMay 2026 FDA Oncology Actions: 8 Approvals Reshape the Landscape
FDA · oncology · 5 min
Dr. Sarah MitchellFDA clears U.S. trial of MAIA lung cancer drug for third-line patients
FDA · lung cancer · 6 min
Dr. Sarah MitchellPharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?
FDA · non-small cell lung cancer · 5 min
Dr. Sarah MitchellAbivax colitis drug hits goal, but cancer cases rattle investors
colitis · 5 min
Dr. Sarah MitchellSupreme Court sides with generic drug maker in icosapent ethyl patent case
U.S. Supreme Court · severe hypertriglyceridemia · 6 min
Dr. Sarah MitchellRx Rundown: Pfizer, Hikma Pharmaceuticals, NewLimit — Drug Approvals & Catalyst Tracker
5 min
Dr. Sarah MitchellMIRA Pharma Consolidates Global Rights to MIRA-55 and SKNY-1
5 min
Dr. Sarah Mitchell4 Biotech Stocks Investors Should Watch in 2026: Market Analysis
4 min
Dr. Sarah MitchellExplore intelligence